Cargando…
Finding the optimal control level of intraoperative blood pressure in no tourniquet primary total knee arthroplasty combine with tranexamic acid: a retrospective cohort study which supports the enhanced recovery strategy
BACKGROUND: With the use of tranexamic acid and control of the blood pressure during the operation, total knee arthroplasty (TKA) without tourniquet can be achieved. There is no exact standard for the control level of blood pressure during no tourniquet TKA. We explored the optimal level of blood pr...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448426/ https://www.ncbi.nlm.nih.gov/pubmed/32843045 http://dx.doi.org/10.1186/s13018-020-01887-0 |
_version_ | 1783574495116656640 |
---|---|
author | Wang, Hao-Yang Yuan, Ming-cheng Pei, Fu-Xing Zhou, Zong-Ke Liao, Ren |
author_facet | Wang, Hao-Yang Yuan, Ming-cheng Pei, Fu-Xing Zhou, Zong-Ke Liao, Ren |
author_sort | Wang, Hao-Yang |
collection | PubMed |
description | BACKGROUND: With the use of tranexamic acid and control of the blood pressure during the operation, total knee arthroplasty (TKA) without tourniquet can be achieved. There is no exact standard for the control level of blood pressure during no tourniquet TKA. We explored the optimal level of blood pressure control during no tourniquet TKA surgery with the use of tranexamic acid in this study. METHODS: Patients underwent TKA were divided into three groups: the mean intraoperative systolic blood pressure in group A was < 90 mmHg, 90–100 mmHg in group B, > 100 mmHg in group C. Total blood loss (TBL), intraoperative blood loss, hidden blood loss, transfusion rate, maximum hemoglobin drop, operation time, and postoperative hospitalization days were recorded. RESULTS: Two hundred seventy-eight patients were enrolled, 82 in group A, 105 in group B, and 91 in group C. Group A (663.3 ± 46.0 ml) and group B (679.9 ± 57.1 ml) had significantly lower TBL than group C (751.7 ± 56.2 ml). Group A (120.2 ± 18.7 ml) had the lowest intraoperative blood loss than groups B and C. Group C (26.0 ± 4.1 g/l) had the largest Hb change than groups A and B. Group A (62.3 ± 4.7 min) had the shortest operation time. The incidence rate of postoperative hypotension in group A (8, 9.8%) was significantly greater than groups B and C. No significant differences were found in other outcomes. CONCLUSION: The systolic blood pressure from 90 to 100 mmHg was the optimal strategy for no tourniquet primary TKA with tranexamic acid. |
format | Online Article Text |
id | pubmed-7448426 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74484262020-08-27 Finding the optimal control level of intraoperative blood pressure in no tourniquet primary total knee arthroplasty combine with tranexamic acid: a retrospective cohort study which supports the enhanced recovery strategy Wang, Hao-Yang Yuan, Ming-cheng Pei, Fu-Xing Zhou, Zong-Ke Liao, Ren J Orthop Surg Res Research Article BACKGROUND: With the use of tranexamic acid and control of the blood pressure during the operation, total knee arthroplasty (TKA) without tourniquet can be achieved. There is no exact standard for the control level of blood pressure during no tourniquet TKA. We explored the optimal level of blood pressure control during no tourniquet TKA surgery with the use of tranexamic acid in this study. METHODS: Patients underwent TKA were divided into three groups: the mean intraoperative systolic blood pressure in group A was < 90 mmHg, 90–100 mmHg in group B, > 100 mmHg in group C. Total blood loss (TBL), intraoperative blood loss, hidden blood loss, transfusion rate, maximum hemoglobin drop, operation time, and postoperative hospitalization days were recorded. RESULTS: Two hundred seventy-eight patients were enrolled, 82 in group A, 105 in group B, and 91 in group C. Group A (663.3 ± 46.0 ml) and group B (679.9 ± 57.1 ml) had significantly lower TBL than group C (751.7 ± 56.2 ml). Group A (120.2 ± 18.7 ml) had the lowest intraoperative blood loss than groups B and C. Group C (26.0 ± 4.1 g/l) had the largest Hb change than groups A and B. Group A (62.3 ± 4.7 min) had the shortest operation time. The incidence rate of postoperative hypotension in group A (8, 9.8%) was significantly greater than groups B and C. No significant differences were found in other outcomes. CONCLUSION: The systolic blood pressure from 90 to 100 mmHg was the optimal strategy for no tourniquet primary TKA with tranexamic acid. BioMed Central 2020-08-25 /pmc/articles/PMC7448426/ /pubmed/32843045 http://dx.doi.org/10.1186/s13018-020-01887-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Wang, Hao-Yang Yuan, Ming-cheng Pei, Fu-Xing Zhou, Zong-Ke Liao, Ren Finding the optimal control level of intraoperative blood pressure in no tourniquet primary total knee arthroplasty combine with tranexamic acid: a retrospective cohort study which supports the enhanced recovery strategy |
title | Finding the optimal control level of intraoperative blood pressure in no tourniquet primary total knee arthroplasty combine with tranexamic acid: a retrospective cohort study which supports the enhanced recovery strategy |
title_full | Finding the optimal control level of intraoperative blood pressure in no tourniquet primary total knee arthroplasty combine with tranexamic acid: a retrospective cohort study which supports the enhanced recovery strategy |
title_fullStr | Finding the optimal control level of intraoperative blood pressure in no tourniquet primary total knee arthroplasty combine with tranexamic acid: a retrospective cohort study which supports the enhanced recovery strategy |
title_full_unstemmed | Finding the optimal control level of intraoperative blood pressure in no tourniquet primary total knee arthroplasty combine with tranexamic acid: a retrospective cohort study which supports the enhanced recovery strategy |
title_short | Finding the optimal control level of intraoperative blood pressure in no tourniquet primary total knee arthroplasty combine with tranexamic acid: a retrospective cohort study which supports the enhanced recovery strategy |
title_sort | finding the optimal control level of intraoperative blood pressure in no tourniquet primary total knee arthroplasty combine with tranexamic acid: a retrospective cohort study which supports the enhanced recovery strategy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448426/ https://www.ncbi.nlm.nih.gov/pubmed/32843045 http://dx.doi.org/10.1186/s13018-020-01887-0 |
work_keys_str_mv | AT wanghaoyang findingtheoptimalcontrollevelofintraoperativebloodpressureinnotourniquetprimarytotalkneearthroplastycombinewithtranexamicacidaretrospectivecohortstudywhichsupportstheenhancedrecoverystrategy AT yuanmingcheng findingtheoptimalcontrollevelofintraoperativebloodpressureinnotourniquetprimarytotalkneearthroplastycombinewithtranexamicacidaretrospectivecohortstudywhichsupportstheenhancedrecoverystrategy AT peifuxing findingtheoptimalcontrollevelofintraoperativebloodpressureinnotourniquetprimarytotalkneearthroplastycombinewithtranexamicacidaretrospectivecohortstudywhichsupportstheenhancedrecoverystrategy AT zhouzongke findingtheoptimalcontrollevelofintraoperativebloodpressureinnotourniquetprimarytotalkneearthroplastycombinewithtranexamicacidaretrospectivecohortstudywhichsupportstheenhancedrecoverystrategy AT liaoren findingtheoptimalcontrollevelofintraoperativebloodpressureinnotourniquetprimarytotalkneearthroplastycombinewithtranexamicacidaretrospectivecohortstudywhichsupportstheenhancedrecoverystrategy |